Kaida BioPharma develops therapies for treatment-resistant gynecological cancers, focusing on ovarian cancer and hormone-driven diseases.
Kaida BioPharma has raised $1.6M in total funding. The most recent round was Seed. The last funding was announced in January 2026.
Kaida BioPharma is headquartered in Fort Lauderdale, United States.
Kaida BioPharma develops therapies for treatment-resistant gynecological cancers, focusing on ovarian cancer and hormone-driven diseases.
Kaida BioPharma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kaida BioPharma — Funding & Investors." VCBacked, January 21, 2026, https://www.vcbacked.co/company/kaida-biopharma. Accessed July 22, 2026.
VCBacked. (2026). Kaida BioPharma — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/kaida-biopharma
{{cite web |title=Kaida BioPharma — Funding & Investors |url=https://www.vcbacked.co/company/kaida-biopharma |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated